Share on StockTwits

Analysts at Stifel Nicolaus assumed coverage on shares of Thermo Fisher Scientific (NYSE:TMO) in a research report issued to clients and investors on Monday, TheFlyOnTheWall.com reports. The firm set a “buy” rating on the stock.

Shares of Thermo Fisher Scientific (NYSE:TMO) traded down 0.20% on Monday, hitting $120.92. 886,577 shares of the company’s stock traded hands. Thermo Fisher Scientific has a 52-week low of $88.13 and a 52-week high of $127.63. The stock’s 50-day moving average is $120.4 and its 200-day moving average is $119.2. The company has a market cap of $48.290 billion and a price-to-earnings ratio of 31.49. Thermo Fisher Scientific also saw unusually large options trading activity on Friday. Traders purchased 2,559 call options on the company. This represents an increase of approximately 170% compared to the average daily volume of 947 call options.

Thermo Fisher Scientific (NYSE:TMO) last released its earnings data on Wednesday, July 23rd. The company reported $1.72 EPS for the quarter, beating the Thomson Reuters consensus estimate of $1.62 by $0.10. The company had revenue of $4.32 billion for the quarter, compared to the consensus estimate of $4.25 billion. During the same quarter in the prior year, the company posted $1.32 earnings per share. The company’s quarterly revenue was up 33.4% on a year-over-year basis. Analysts expect that Thermo Fisher Scientific will post $6.94 EPS for the current fiscal year.

The company also recently announced a quarterly dividend, which is scheduled for Wednesday, October 15th. Shareholders of record on Monday, September 15th will be paid a dividend of $0.15 per share. This represents a $0.60 annualized dividend and a dividend yield of 0.50%. The ex-dividend date is Thursday, September 11th.

In other Thermo Fisher Scientific news, VP Seth H. Hoogasian unloaded 5,103 shares of the stock on the open market in a transaction that occurred on Wednesday, July 30th. The shares were sold at an average price of $123.82, for a total transaction of $631,853.46. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link.

A number of other firms have also recently commented on TMO. Analysts at Zacks reiterated a “neutral” rating on shares of Thermo Fisher Scientific in a research note on Thursday. They now have a $126.00 price target on the stock. Separately, analysts at Macquarie reiterated an “outperform” rating on shares of Thermo Fisher Scientific in a research note on Thursday, July 24th. They now have a $135.00 price target on the stock, up previously from $130.00. Finally, analysts at Citigroup Inc. initiated coverage on shares of Thermo Fisher Scientific in a research note on Thursday, July 17th. They set a “buy” rating on the stock. Two investment analysts have rated the stock with a hold rating and eleven have assigned a buy rating to the company. Thermo Fisher Scientific currently has a consensus rating of “Buy” and an average price target of $133.42.

Thermo Fisher Scientific Inc (NYSE:TMO) is engaged in serving science.

The Fly On The Wall

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.